A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease

Update Il y a 4 ans
Reference: NCT02665234

Woman and Man

Extract

The purpose of this study is to assess the safety and efficacy of Tavilermide Ophthalmic Solution compared with Placebo Ophthalmic Solution in treating the signs and symptoms of dry eye disease.


Inclusion criteria

  • Keratoconjunctivitis Sicca

Links